Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HK-care ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   6.9% 7.2% 8.6% 19.1% 11.5% 14.0% 15.9% 15.9%   Credit score (0-100)   36 35 28 6 20 15 12 12   Credit rating   BBB BBB BB B BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   349 253 254 -38.7 199 236 0.0 0.0   EBITDA   60.1 -15.4 124 -188 179 16.6 0.0 0.0   EBIT   46.1 -37.0 94.9 -218 155 8.6 0.0 0.0   Pre-tax profit (PTP)   32.6 -51.0 76.8 -228.5 142.5 -10.7 0.0 0.0   Net earnings   24.7 -39.8 59.8 -178.4 111.2 -8.4 0.0 0.0   Pre-tax profit without non-rec. items   32.6 -51.0 76.8 -228 143 -10.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   45.2 123 93.9 64.5 40.0 32.0 0.0 0.0   Shareholders equity total   38.4 -1.5 58.3 -120 -8.9 -17.3 -57.3 -57.3   Interest-bearing liabilities   156 169 58.4 163 48.2 50.1 57.3 57.3   Balance sheet total (assets)   307 295 338 272 237 139 0.0 0.0   Net Debt   151 169 58.4 163 21.0 35.9 57.3 57.3     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   349 253 254 -38.7 199 236 0.0 0.0   Gross profit growth   755.0% -27.7% 0.4% 0.0% 0.0% 18.4% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   307 295 338 272 237 139 0 0   Balance sheet change%   13.8% -3.9% 14.5% -19.5% -12.8% -41.4% -100.0% 0.0%   Added value   60.1 -15.4 124.3 -188.2 184.1 16.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -28 56 -59 -59 -49 -16 -32 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.2% -14.7% 37.4% 562.4% 77.6% 3.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.0% -12.3% 29.9% -59.2% 48.7% 4.3% 0.0% 0.0%   ROI %   21.0% -16.6% 43.8% -112.2% 123.7% 17.8% 0.0% 0.0%   ROE %   95.1% -23.9% 33.8% -108.0% 43.6% -4.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   12.5% -0.5% 17.3% -30.6% -3.6% -11.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   252.0% -1,100.8% 47.0% -86.8% 11.7% 215.7% 0.0% 0.0%   Gearing %   406.1% -11,551.6% 100.2% -136.1% -540.3% -289.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.0% 8.6% 16.0% 11.3% 12.3% 39.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.2 0.5 0.3 0.2 0.3 0.0 0.0   Current Ratio   1.4 0.8 1.1 0.6 0.8 0.7 0.0 0.0   Cash and cash equivalent   4.4 0.0 0.0 0.0 27.2 14.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   79.0 -42.1 29.2 -144.7 -48.9 -49.3 -28.6 -28.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 17 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 17 0 0   EBIT / employee   0 0 0 0 0 9 0 0   Net earnings / employee   0 0 0 0 0 -8 0 0